InvestorsHub Logo
Followers 87
Posts 6704
Boards Moderated 1
Alias Born 09/18/2009

Re: KLee post# 122127

Thursday, 10/08/2020 7:24:20 PM

Thursday, October 08, 2020 7:24:20 PM

Post# of 233206
There have been two FOX news interviews concerning potential breakthroughs in the treatment of coronavirus within the last week or so.

https://www.msn.com/en-us/health/other/potential-breakthrough-coronavirus-treatment/vi-BB19FOgW

https://video.foxbusiness.com/v/6198423662001/#sp=show-clips

I have followed both of these companies for years, and now have added CYDY to my holdings in HGEN, where I have had a position since 2017.

Both of these companies have products with long developmental histories, that were designed to treat other indications than Covid.

Both are expecting interim Phase III results very soon, with promising results already known from prior trials and studies.

In viewing the videos, you will see a distinct contrast in the guidance given by the CEO's. Nader, CEO of CYDY, seems to think the FDA will grant approval of lero after reviewing the interim Phase III data, at least that's how I interpret what he says.

Cameron, CEO of HGEN, simply says they plan to submit Phase III results, showing very exciting data, to the FDA by the end of the year. In reality, the company has a Q4 target for obtaining an Emergency Use Authorization (EUA), which he is discussing with the FDA already, based on the interim results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News